Zurcher Kantonalbank (Zurich Cantonalbank) - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$611,078
-10.4%
22,742
+19.0%
0.00%0.0%
Q2 2023$681,748
+51.3%
19,118
+7.8%
0.00%
+50.0%
Q1 2023$450,571
-24.9%
17,739
+19.9%
0.00%
-33.3%
Q4 2022$600,329
+37.4%
14,801
+12.0%
0.00%0.0%
Q3 2022$437,000
-6.0%
13,2190.0%0.00%0.0%
Q2 2022$465,000
-23.8%
13,219
-0.3%
0.00%0.0%
Q1 2022$610,000
-37.4%
13,258
-9.7%
0.00%
-40.0%
Q4 2021$974,000
+42.6%
14,690
+34.2%
0.01%
+25.0%
Q3 2021$683,000
-24.8%
10,947
-0.1%
0.00%
-20.0%
Q2 2021$908,000
+18.2%
10,958
-5.4%
0.01%0.0%
Q1 2021$768,000
-16.0%
11,582
-2.8%
0.01%
-16.7%
Q4 2020$914,000
+92.4%
11,911
+8.0%
0.01%
+100.0%
Q3 2020$475,000
-0.4%
11,0330.0%0.00%
-25.0%
Q2 2020$477,000
+102.1%
11,033
+34.3%
0.00%
+100.0%
Q1 2020$236,000
-34.8%
8,218
+44.2%
0.00%
-33.3%
Q4 2019$362,000
+124.8%
5,7010.0%0.00%
+200.0%
Q3 2019$161,000
+17.5%
5,701
+10.3%
0.00%0.0%
Q2 2019$137,000
+44.2%
5,1700.0%0.00%0.0%
Q1 2019$95,000
+3.3%
5,170
-30.0%
0.00%0.0%
Q4 2018$92,000
-35.2%
7,3850.0%0.00%0.0%
Q3 2018$142,000
+42.0%
7,3850.0%0.00%0.0%
Q2 2018$100,000
+4900.0%
7,385
+450.3%
0.00%
Q1 2017$2,0000.0%1,3420.0%0.00%
Q4 2016$2,000
-80.0%
1,3420.0%0.00%
Q3 2016$10,000
+42.9%
1,3420.0%0.00%
Q2 2016$7,0001,3420.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders